Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,
    Business,  Benzinga,  Biotechnology,  Health,  Technology

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022 /

    This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body.  Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery.  Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…

    read more
    Jessica N. Abraham Comments Off on MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    You May Also Like

    dare day, ramona, beverly cleary, beverly clearly, cleveland, painesville, warren, ohio authors, warren local news, child writer,

    Celebrate D.E.A.R. Day 2021 with three new children’s books, written by local authors

    March 1, 2021
    SEO, Search Engine Optimization, Flash, Wix, Static, Responsive, The Vault, Examiner, Websites, Widgets, Applications, HTML 5,

    Flash and SEO will NEVER MARRY… They are too wrong for each other!

    April 23, 2013
    Healthcare Apps, Unified Communications, WebRTC, IoT, RFID, Healthcare Solutions, RTC, Web RTC, Real Time Communications, Unified Communications, Remote Collaboration, Enterprise Collaboration, Enterprise Solutions, Business Solutions, Contact Center, Remote Workforce, TMC Net, TMCNet, Technology News, Tech News, Technology Marketing News,

    ShoreTel Expands Globalization Growth Through HYBRID System and Voxbone Partnership

    March 2, 2016
  • Statera Pharmaceuticals treatment for Covid-19 Long-Haulers
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…

    read more
    Jessica N. Abraham Comments Off on Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    You May Also Like

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021
    Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021
    What's the difference between Marijuana, Cannabis and Hemp -- industrial Hemp, CBD, Farm Bill, Agricultural Act, Generation Hemp, GENH

    Cannabis Investors Should Know the Difference Between Marijuana and Hemp

    July 19, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    Healthcare Apps, Unified Communications, WebRTC, IoT, RFID, Healthcare Solutions, RTC, Web RTC, Real Time Communications, Unified Communications, Remote Collaboration, Enterprise Collaboration, Enterprise Solutions, Business Solutions, Contact Center, Remote Workforce, TMC Net, TMCNet, Technology News, Tech News, Technology Marketing News,

    Empire Access Ditches Legacy Systems, Implements GENBAND

    February 16, 2016
    All Electric Race Series, Ferrari, Tesla, Worksport, Terravis Energy, Polaris, KULR, Greenland Technologies, KULR, Phoenix Startups, Arizona Startups, StartEngine Startups, Battle Approved Motors, The Battle Ground, BAM, Chris James, Racing, Electric Vehicles, EVs, UTVs, Utility Terrain Vehicles, ATVs, All Terrain Vehicles, Glamping, Racing, NASCAR,

    What is a UTV, and Why Might Investing in BAM be a Good Idea?

    July 22, 2021
    Charity,Donations,Event Invites,Event Marketing,Examiner,Fundraising,Industry Tools,Live Events,Non-Profit Organizations,RSVP,The Vault,Ticket Sites,TicketForce,Marketing Tools,Web Tools, Ticket Kiosks, Events with a Cause,

    Event with a cause: TicketForce unveils new implementation tool for non profits

    December 23, 2013
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    Hemp-based animal bedding for small animals and farms -- pest free, pesticide free, mold-free, antibacterial, safe, edible.

    Industrial Hemp: Big Win for Pet Stores, Farmers, and Animals

    October 25, 2021
    MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022
    Smart Buildings, HVAC, Indoor Air Quality, WiFi, Connected Devices, Internet of things, IoT,

    Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever

    September 7, 2021
  • Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics
    Business,  Benzinga,  Finance,  Health,  Regenerative Medicine

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Age-related macular degeneration (AMD) is a disease originating in the retina, which may worsen over time, according to WebMD. It’s said to be the leading cause of severe, permanent vision loss in people older than 60.  When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the back of the eye begins to deteriorate. While it doesn’t always cause complete blindness, severe vision problems such as loss of central vision may occur. As the condition worsens,…

    read more
    Jessica N. Abraham Comments Off on Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    You May Also Like

    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding Team Building, Leadership, Workforce Optimization, Corporate Development,

    Coaching life changes for the active personality styles

    April 24, 2019
    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding, Team Building, Leadership, Workforce Optimization, Corporate Development, Business Development, Business Expansion, Growth, Team Building, Culture, Building Remote Teams, Compliances, Roles, Infrastructure, Differences in Opinion,

    Turn your consulting energy into coaching revenue

    January 14, 2020
    axs, Florida Hip Hop,Opportunities,FM Radio,Independent Artists,Independent Music,Major Label Artists,Playas Mob Radio,Promotion,Radio Promotion,Traditional Media

    Playas Mob Radio: Excellent platform for independents to shine alongside majors

    November 22, 2014
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.